The timing depends on patent litigation outcomes, which DrugPatentWatch tracks in real time through its patent expiration databases and ANDA filing data
Building upon the established effects of GLP-1 receptor agonists, dual GCG/GLP-1 receptor agonists simultaneously improve the two core pathogenic mechanisms of diabetes - insufficient insulin secretion and insulin resistance, thus, delivering comprehensive benefits beyond glycemic control, including weight loss, and hepato-cardio-renal metabolic improvements
Estimated delivery between July 31 and August 02
Peripheral Oxyntomodulin Reduces Food Intake and Body Weight Gain in Rats
Though nicotine causes changes in the brain, cigarettes cause changes to the fats in your body, further increasing CVD risk
The clinical presentation was determined to be consistent with non-arteritic anterior ischemic optic neuropathy (NA-AION) in the right eye